SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045279
Filing Date
2013-08-13
Accepted
2013-08-13 17:25:38
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v351584_10q.htm 10-Q 676737
2 EX-31.1 v351584_ex31-1.htm EX-31.1 28276
3 EX-31.2 v351584_ex31-2.htm EX-31.2 28453
4 EX-32.1 v351584_ex32-1.htm EX-32.1 10400
5 EX-32.2 v351584_ex32-2.htm EX-32.2 10391
  Complete submission text file 0001144204-13-045279.txt   4789052

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20130630.xml EX-101.INS 406373
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20130630.xsd EX-101.SCH 35228
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20130630_cal.xml EX-101.CAL 24419
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20130630_def.xml EX-101.DEF 153296
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20130630_lab.xml EX-101.LAB 234365
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20130630_pre.xml EX-101.PRE 183560
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 131034032
SIC: 2834 Pharmaceutical Preparations